CPE is a member of metallocarboxypeptidases family, and the CPE mRNA expression level can predict tumor recurrence in early-stage hepatocellular carcinoma, and predict poor prognosis in early-stage cervical cancer (Huang et al., 2016b; Shen et al., 2016). This evidence concerns the gene CPE and cervical cancer.